14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $22.23 $23.98 Wednesday, 24th Apr 2024 EXEL stock ended at $23.71. This is 1.80% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.54% from a day low at $23.19 to a day high of $23.78.
90 days $20.02 $24.07
52 weeks $18.08 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
Oct 24, 2023 $19.29 $19.84 $19.29 $19.61 3 552 358
Oct 23, 2023 $21.12 $21.12 $18.64 $19.25 7 021 339
Oct 20, 2023 $20.88 $21.20 $20.85 $21.11 2 690 801
Oct 19, 2023 $21.26 $21.26 $20.45 $20.83 2 048 689
Oct 18, 2023 $21.78 $21.78 $21.33 $21.35 1 594 102
Oct 17, 2023 $21.54 $21.90 $21.48 $21.78 1 931 982
Oct 16, 2023 $21.38 $21.66 $21.22 $21.57 2 176 000
Oct 13, 2023 $21.21 $21.36 $21.05 $21.36 2 106 163
Oct 12, 2023 $21.57 $21.57 $21.12 $21.24 2 315 416
Oct 11, 2023 $21.54 $21.72 $21.40 $21.50 1 641 886
Oct 10, 2023 $21.53 $21.78 $21.51 $21.61 1 496 220
Oct 09, 2023 $21.98 $22.03 $21.10 $21.49 2 289 430
Oct 06, 2023 $22.05 $22.35 $22.03 $22.22 1 656 037
Oct 05, 2023 $21.76 $22.25 $21.76 $22.14 1 566 177
Oct 04, 2023 $21.85 $21.86 $21.63 $21.76 2 755 127
Oct 03, 2023 $22.19 $22.24 $21.76 $21.88 1 351 480
Oct 02, 2023 $21.98 $22.32 $21.81 $22.22 2 003 580
Sep 29, 2023 $22.35 $22.42 $21.81 $21.85 2 061 047
Sep 28, 2023 $22.19 $22.51 $22.09 $22.39 3 560 792
Sep 27, 2023 $21.81 $22.19 $21.79 $22.19 2 006 525
Sep 26, 2023 $21.84 $22.12 $21.74 $21.75 1 384 568
Sep 25, 2023 $21.62 $21.99 $21.51 $21.83 1 761 511
Sep 22, 2023 $21.60 $21.75 $21.44 $21.48 2 213 125
Sep 21, 2023 $21.50 $21.80 $21.46 $21.58 1 913 322
Sep 20, 2023 $21.44 $21.63 $21.30 $21.51 1 345 053
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT